Press Release Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology Jul 21
Press Release Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Jul 9